These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31712905)
1. Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl'ONE Results. Nofrerias I; Nardi A; Suñé-Pou M; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Miñarro M; Bataille B; Ticó JR AAPS PharmSciTech; 2019 Nov; 21(1):1. PubMed ID: 31712905 [TBL] [Abstract][Full Text] [Related]
2. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression. Saurí J; Millán D; Suñé-Negre JM; Pérez-Lozano P; Sarrate R; Fàbregas A; Carrillo C; Miñarro M; Ticó JR; García-Montoya E Int J Pharm; 2014 Jan; 461(1-2):38-45. PubMed ID: 24284019 [TBL] [Abstract][Full Text] [Related]
3. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients. Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129 [TBL] [Abstract][Full Text] [Related]
4. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation. Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387 [TBL] [Abstract][Full Text] [Related]
5. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system. Gülbağ S; Yılmaz Usta D; Gültekin HE; Oktay AN; Demirtaş Ö; Karaküçük A; Çelebi N Pharm Dev Technol; 2018 Jun; 23(5):512-519. PubMed ID: 28657404 [TBL] [Abstract][Full Text] [Related]
6. Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index. Nofrerias I; Nardi A; Suñé-Pou M; Boeckmans J; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Ticó-Grau JR; Miñarro-Carmona M PLoS One; 2018; 13(9):e0203846. PubMed ID: 30212557 [TBL] [Abstract][Full Text] [Related]
7. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System. Zieschang L; Klein M; Jung N; Krämer J; Windbergs M Eur J Pharm Biopharm; 2019 Nov; 144():68-78. PubMed ID: 31493511 [TBL] [Abstract][Full Text] [Related]
8. SeDeM Expert System, an Innovative Tool for Developing Directly Compressible Tablets: A Review. Singh I; Thakur AK; Bala R; Madan R Curr Drug Res Rev; 2021; 13(1):16-24. PubMed ID: 32988362 [TBL] [Abstract][Full Text] [Related]
9. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system I: pellets with different sizes. Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp JH Pharm Dev Technol; 2018 Sep; 23(7):706-714. PubMed ID: 28612663 [TBL] [Abstract][Full Text] [Related]
10. Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press. Lura A; Elezaj V; Kokott M; Fischer B; Breitkreutz J Int J Pharm; 2021 Jun; 602():120636. PubMed ID: 33895296 [TBL] [Abstract][Full Text] [Related]
11. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets. Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910 [TBL] [Abstract][Full Text] [Related]
12. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT. Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435 [TBL] [Abstract][Full Text] [Related]
13. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156 [TBL] [Abstract][Full Text] [Related]
14. Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (IH) and relative humidity (%RH). Suñé-Negre JM; Pérez-Lozano P; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Miñarro M; Ticó JR Eur J Pharm Biopharm; 2011 Oct; 79(2):464-72. PubMed ID: 21501683 [TBL] [Abstract][Full Text] [Related]
15. Application of SeDeM Expert system in formulation development of effervescent tablets by direct compression. Khan A; Iqbal Z; Rehman Z; Nasir F; Khan A; Ismail M; Roohullah ; Mohammad A Saudi Pharm J; 2014 Nov; 22(5):433-44. PubMed ID: 25473332 [TBL] [Abstract][Full Text] [Related]
16. Assessing disintegration effectiveness: A thorough evaluation using the SeDeM-ODT expert system for doxylamine succinate orodispersible formulation. Ahmad SA; Hasan SMF; Bafail D; Shah SF; Imran M; Sahar T; Ishaqui AA PLoS One; 2024; 19(9):e0310334. PubMed ID: 39288134 [TBL] [Abstract][Full Text] [Related]
17. An overview of the implementation of SeDeM and SSCD in various formulation developments. Gaikwad SS; Kothule AM; Morade YY; Patil SS; Laddha UD; Kshirsagar SJ; Salunkhe KS Int J Pharm; 2023 Mar; 635():122699. PubMed ID: 36764417 [TBL] [Abstract][Full Text] [Related]
18. Challenges in the transfer and scale-up of mini-tableting: Case study with losartan potassium. Lura V; Klinken S; Breitkreutz J Eur J Pharm Biopharm; 2023 Nov; 192():161-173. PubMed ID: 37820883 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotechnical Evaluation by SeDeM Expert System to Develop Orodispersible Tablets. Rao MRP; Sapate S; Sonawane A AAPS PharmSciTech; 2022 May; 23(5):133. PubMed ID: 35534652 [TBL] [Abstract][Full Text] [Related]
20. A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products. Pérez P; Suñé-Negre JM; Miñarro M; Roig M; Fuster R; García-Montoya E; Hernández C; Ruhí R; Ticó JR Eur J Pharm Biopharm; 2006 Nov; 64(3):351-9. PubMed ID: 16949262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]